Terms: = Ovarian cancer AND KLK2, P20151, 3817, ENSG00000167751, MGC12201, hK2, KLK2A2
63 results:
1. Cryptotanshinone suppresses ovarian cancer via simultaneous inhibition of glycolysis and oxidative phosphorylation.
Wang T; Zhang M; Khan M; Li J; Wu X; Ma T; Li Y
Biomed Pharmacother; 2024 Jan; 170():115956. PubMed ID: 38039759
[TBL] [Abstract] [Full Text] [Related]
2. The effect of cuproptosis-relevant genes on the immune infiltration and metabolism of gynecological oncology by multiply analysis and experiments validation.
Ran XM; Xiao H; Tang YX; Jin X; Tang X; Zhang J; Li H; Li YK; Tang ZZ
Sci Rep; 2023 Nov; 13(1):19474. PubMed ID: 37945610
[TBL] [Abstract] [Full Text] [Related]
3. CircRNA-regulated glucose metabolism in ovarian cancer: an emerging landscape for therapeutic intervention.
Wang Y; Chen X; Yang Y
Clin Transl Oncol; 2024 Mar; 26(3):584-596. PubMed ID: 37578652
[TBL] [Abstract] [Full Text] [Related]
4. Intra-racial disaggregation reveals associations between nativity and overall survival in women with endometrial cancer.
Mercadel AJ; Sanchez-Covarrubias AP; Medina HN; Pinheiro PS; Pinto A; George SHL; Schlumbrecht MP
Gynecol Oncol; 2023 Sep; 176():98-105. PubMed ID: 37480810
[TBL] [Abstract] [Full Text] [Related]
5. A comparative study of [
Xi Y; Sun L; Che X; Huang X; Liu H; Wang Q; Meng H; Miao Y; Qu Q; Hai W; Li B; Feng W
Eur J Nucl Med Mol Imaging; 2023 Jul; 50(9):2885-2898. PubMed ID: 37093313
[TBL] [Abstract] [Full Text] [Related]
6. PIM2 Promotes the Development of ovarian Endometriosis by Enhancing Glycolysis and Fibrosis.
Wang M; Fan R; Jiang J; Sun F; Sun Y; Wang Q; Jiang A; Yu Z; Yang T
Reprod Sci; 2023 Sep; 30(9):2692-2702. PubMed ID: 37059967
[TBL] [Abstract] [Full Text] [Related]
7. Glycolysis Inhibition of Autophagy Drives Malignancy in ovarian cancer: Exacerbation by IL-6 and Attenuation by Resveratrol.
Vidoni C; Ferraresi A; Vallino L; Salwa A; Ha JH; Seca C; Garavaglia B; Dhanasekaran DN; Isidoro C
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675246
[TBL] [Abstract] [Full Text] [Related]
8. Hexokinase 2 promoted cell motility and proliferation by activating Akt1/p-Akt1 in human ovarian cancer cells.
Tian X; Liu D; Zuo X; Sun X; Wu M; Li X; Teng Y
J Ovarian Res; 2022 Aug; 15(1):92. PubMed ID: 35953860
[TBL] [Abstract] [Full Text] [Related]
9. miR-532-3p suppresses proliferation and invasion of ovarian cancer cells via GPNMB/HIF-1α/hk2 axis.
Tuo X; Zhou Y; Yang X; Ma S; Liu D; Zhang X; Hou H; Wang R; Li X; Zhao L
Pathol Res Pract; 2022 Sep; 237():154032. PubMed ID: 35914373
[TBL] [Abstract] [Full Text] [Related]
10. Downregulation of DNMT3A Attenuates the Warburg Effect, Proliferation, and Invasion via Promoting the Inhibition of miR-603 on hk2 in ovarian cancer.
Lu J; Zhen S; Tuo X; Chang S; Yang X; Zhou Y; Chen W; Zhao L; Li X
Technol Cancer Res Treat; 2022; 21():15330338221110668. PubMed ID: 35770296
[No Abstract] [Full Text] [Related]
11. HIF-1
Lyu Y; Zhang Y; Wang Y; Luo Y; Ding H; Li P; Ni G
J Immunol Res; 2022; 2022():6130806. PubMed ID: 35733918
[TBL] [Abstract] [Full Text] [Related]
12. MFAP2 aggravates tumor progression through activating FOXM1/β-catenin-mediated glycolysis in ovarian cancer.
Zhao LQ; Sun W; Zhang P; Gao W; Fang CY; Zheng AW
Kaohsiung J Med Sci; 2022 Aug; 38(8):772-780. PubMed ID: 35546486
[TBL] [Abstract] [Full Text] [Related]
13. CircCDK17 knockdown inhibits tumor progression and cell glycolysis by downregulaing YWHAZ expression through sponging miR-1294 in cervical cancer.
Chen R; Liang F; Yan J; Wang Y
J Ovarian Res; 2022 Feb; 15(1):24. PubMed ID: 35168653
[TBL] [Abstract] [Full Text] [Related]
14. TRPM7 silencing modulates glucose metabolic reprogramming to inhibit the growth of ovarian cancer by enhancing AMPK activation to promote HIF-1α degradation.
Chen Y; Liu L; Xia L; Wu N; Wang Y; Li H; Chen X; Zhang X; Liu Z; Zhu M; Liao Q; Wang J
J Exp Clin Cancer Res; 2022 Jan; 41(1):44. PubMed ID: 35101076
[TBL] [Abstract] [Full Text] [Related]
15. An Experimentally Induced Mutation in the UBA Domain of p62 Changes the Sensitivity of Cisplatin by Up-Regulating hk2 Localisation on the Mitochondria and Increasing Mitophagy in A2780 ovarian cancer Cells.
Yu S; Yan X; Tian R; Xu L; Zhao Y; Sun L; Su J
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33924293
[TBL] [Abstract] [Full Text] [Related]
16. PGC1α Promotes Cisplatin Resistance in ovarian cancer by Regulating the HSP70/hk2/VDAC1 Signaling Pathway.
Li Y; Kang J; Fu J; Luo H; Liu Y; Li Y; Sun L
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33802591
[TBL] [Abstract] [Full Text] [Related]
17. Wnt/β-catenin agonist BIO alleviates cisplatin-induced nephrotoxicity without compromising its efficacy of anti-proliferation in ovarian cancer.
Sun Z; Xu S; Cai Q; Zhou W; Jiao X; Bao M; Yu X
Life Sci; 2020 Dec; 263():118672. PubMed ID: 33121990
[TBL] [Abstract] [Full Text] [Related]
18. Circular RNA circRHOBTB3 inhibits ovarian cancer progression through PI3K/AKT signaling pathway.
Sun Y; Liu Y; Chen H; Tan Y
Panminerva Med; 2024 Mar; 66(1):36-46. PubMed ID: 32720791
[TBL] [Abstract] [Full Text] [Related]
19. Aurora-A/SOX8/FOXK1 signaling axis promotes chemoresistance via suppression of cell senescence and induction of glucose metabolism in ovarian cancer organoids and cells.
Sun H; Wang H; Wang X; Aoki Y; Wang X; Yang Y; Cheng X; Wang Z; Wang X
Theranostics; 2020; 10(15):6928-6945. PubMed ID: 32550913
[No Abstract] [Full Text] [Related]
20. Bcl2 inhibitor ABT737 reverses the Warburg effect via the Sirt3-HIF1α axis to promote oxidative stress-induced apoptosis in ovarian cancer cells.
Dong D; Dong Y; Fu J; Lu S; Yuan C; Xia M; Sun L
Life Sci; 2020 Aug; 255():117846. PubMed ID: 32470451
[TBL] [Abstract] [Full Text] [Related]
[Next]
